Stroke News and Research

RSS

A stroke is a medical emergency. Strokes happen when blood flow to your brain stops. Within minutes, brain cells begin to die. There are two kinds of stroke. The more common kind, called ischemic stroke, is caused by a blood clot that blocks or plugs a blood vessel in the brain. The other kind, called hemorrhagic stroke, is caused by a blood vessel that breaks and bleeds into the brain. "Mini-strokes" or transient ischemic attacks (TIAs), occur when the blood supply to the brain is briefly interrupted.

ARV drug atazanavir may have significant effects on infant development

The antiretroviral (ARV) drug atazanavir—sometimes included in treatments to prevent mother-to-child HIV transmission during pregnancy—may have small but significant effects on infant development, reports a study in the journal AIDS, official journal of the International AIDS Society.

23 Feb 2016

Damage to language network structural hubs can affect severity of aphasia following stroke

When brain regions that control speech and reading comprehension are destroyed due to blockage of blood flow, patients are often unable to speak or comprehend spoken or written language. These difficulties with language, or "aphasia," are a common symptom in the aftermath of stroke. However, in a new study published in Restorative Neurology and Neuroscience, researchers report that damage to the underlying connections among different areas of the brain can also affect the severity of aphasia.

23 Feb 2016

New treatment for adults with lazy eye one step closer to reality

A new treatment for adults with lazy eye, a condition previously thought to be treatable only in childhood, is one step closer as a result of research from the University of Waterloo in Canada and Sun Yat-sen University in China.

23 Feb 2016

New CODMAN ENTERPRISE 2 Vascular Reconstruction Device launched for treatment of intracranial aneurysms

Codman Neuro has launched the CODMAN ENTERPRISE 2 Vascular Reconstruction Device, the latest generation of the company’s self-expanding stent and delivery system used to treat wide-necked intracranial aneurysms and to help maintain the position of endovascular coils during and after the procedure.

23 Feb 2016

National Stroke Association reports positive outcomes from Stroke Recovery Navigator program

National Stroke Association released today the promising results from the pilot of its Stroke Recovery Navigator program (SRN) at the International Stroke Conference in Los Angeles.

23 Feb 2016

Cardiac clot-busting drug decreases mortality in hemorrhagic stroke patients

Reporting on the results of a phase III international clinical trial, Johns Hopkins Medicine physicians say use of a cardiac clot-busting drug to treat strokes that cause brain bleeding safely decreased the death rate in patients by 10 percent, compared to a control group receiving saline.

23 Feb 2016

MRI for unwitnessed stroke looking promising

Results of the MR WITNESS study suggest that magnetic resonance imaging may be able to identify patients with strokes that can be treated with tissue plasminogen activator, even if the time of symptom onset is unknown.

22 Feb 2016

Increasing medication adherence: an interview with Dr Alejandro (Alex) Jaimes

Adherence applies to multiple levels of healthcare. Before a drug goes on the market it has to undergo testing in clinical trials: participants take the study drug and report how well the drug works, along with any side effects.

22 Feb 2016

Differences in patient education level may compromise safety, efficacy of anticoagulants

Patients with no schooling benefit least from blood thinning medications, reveals a European Heart Rhythm Association / European Society of Cardiology survey published today in Europace.

22 Feb 2016

Stenting and surgery equally effective at lowering long-term risk of stroke

Investigators for the Carotid Revascularization Endarterectomy versus Stenting Trial found that stenting and surgery are equally effective at lowering the long-term risk of stroke from a narrowed carotid artery, according to a study published today in The New England Journal of Medicine.

22 Feb 2016

Briviact (brivaracetam) approved for treatment of partial onset seizures in patients with epilepsy

The U.S. Food and Drug Administration yesterday approved Briviact (brivaracetam) as an add-on treatment to other medications to treat partial onset seizures in patients age 16 years and older with epilepsy.

22 Feb 2016

Over a third of US population not getting enough sleep

A large study of US adults, conducted collaboratively by state health departments and the CDC, has shown that over a third of the population are regularly not getting enough sleep. This is the first study to obtain self-reported estimates of sleep duration for all 50 US states and the District of Columbia.

19 Feb 2016

Wearable robotic exoskeleton may enable multiple sclerosis patients to walk more efficiently

Walking with a wearable robotic exoskeleton may enable people with multiple sclerosis to walk more efficiently by reducing the energy and muscle activity needed to walk, according to research presented this week at the Association for Academic Physiatrists Annual Meeting in Sacramento, Calif.

19 Feb 2016

Rehabilitation-induced reorganization of damaged brain circuits responsible for functional recovery

Each year millions of people worldwide suffer from stroke, which can occur to anyone at any time. While some may recover completely, the majority of survivors will experience some form of impairment that requires a lengthy process toward partial or full recovery of functioning. Therefore, continuous improvement of rehabilitation methods is needed to ensure more positive long-term outcomes among survivors.

19 Feb 2016

Clot-busting drugs decrease mortality in one of worst forms of hemorrhagic stroke

The use of clot-busting drugs to clear blood from the brain's ventricles may be the first effective strategy to decrease mortality for a type of catastrophic bleeding stroke, according to phase-3 clinical trial results announced Thursday at the International Stroke Conference in Los Angeles.

19 Feb 2016

African Americans and Hispanics at higher risk of developing heart failure

More than 915,000 Americans will be diagnosed with heart failure this year, according to the recently published American Heart Association 2016 Statistical Update.

18 Feb 2016

Way forwards CLEARing for IVH intervention

Results of the CLEAR III trial point the way forwards for the treatment of patients with intraventricular haemorrhage.

18 Feb 2016

CREST, ARUBA give long-term updates

Today's late-breaking trials session at the International Stroke Conference featured the long-term results of CREST and ARUBA, both of which support the original trial findings.

18 Feb 2016

U of M, RIT awarded $3 million grant to assess health information between deaf and hearing individuals

Health information can be difficult to understand for anyone, but it is especially difficult for deaf individuals who may struggle with information and health care marginalization. This is a population with high rates of inadequate health literacy and health disparities. A grant from the National Institutes of Health's National Institute on Deafness and Other Communication Disorders is looking to change that.

18 Feb 2016

Motor skill training using exoskeleton device beneficial to people suffering from post-stroke weakness

Motor skill training using a robotic arm exoskeleton may be beneficial to people suffering from post-stroke weakness affecting an entire side of their body, according to research presented this week at the Association of Academic Physiatrists Annual Meeting in Sacramento, Calif.

18 Feb 2016

Stroke News and Research

Further Reading

ARV drug atazanavir may have significant effects on infant development

Damage to language network structural hubs can affect severity of aphasia following stroke

New treatment for adults with lazy eye one step closer to reality

New CODMAN ENTERPRISE 2 Vascular Reconstruction Device launched for treatment of intracranial aneurysms

National Stroke Association reports positive outcomes from Stroke Recovery Navigator program

Cardiac clot-busting drug decreases mortality in hemorrhagic stroke patients

MRI for unwitnessed stroke looking promising

Increasing medication adherence: an interview with Dr Alejandro (Alex) Jaimes

Differences in patient education level may compromise safety, efficacy of anticoagulants

Stenting and surgery equally effective at lowering long-term risk of stroke

Briviact (brivaracetam) approved for treatment of partial onset seizures in patients with epilepsy

Over a third of US population not getting enough sleep

Wearable robotic exoskeleton may enable multiple sclerosis patients to walk more efficiently

Rehabilitation-induced reorganization of damaged brain circuits responsible for functional recovery

Clot-busting drugs decrease mortality in one of worst forms of hemorrhagic stroke

African Americans and Hispanics at higher risk of developing heart failure

Way forwards CLEARing for IVH intervention

CREST, ARUBA give long-term updates

U of M, RIT awarded $3 million grant to assess health information between deaf and hearing individuals

Motor skill training using exoskeleton device beneficial to people suffering from post-stroke weakness

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News